InvestorsHub Logo
icon url

biopharm

05/24/19 3:50 PM

#330465 RE: r622102675 #330464

R66, have you considered what Ken Dart has been promised for maintaining his ownership of Peregrine/Avid thru this shifting of some of the IP assets?

Shouldn't Roche (and others) have learned in their high price paid in tranches, to finally buy out Genentech?

The trading pattern (with Stafford types playing ping pong) has, on the surface, held up at 60% ownership. There are some new IIS that boast about long-term plays and...

If there was ever a time for one of them out there to use SEC rules to conceal their holdings, this is the time. There are many a Big Pharma families that know how to play well in the sandbox surrounding drug pricing (recently exposed)

Patent laws were just shaken up in allowing Dana Farber share patents they collaborated on and now, those dozens of collaborations held by Peregrine Pharmaceuticals are quite critical ...as ANY improvement such as Biomarkers etc etc that were developed out of such collaborations is good reason Stafford was the hired gun to confuse what has been going on.

Targeting flipped PS occurs upstream and there are now techniques to prove the order of events that take place ...from Thermo Fisher to GE to Berkeley Lights etc, and some will stop at nothing to hide those facts.

IIS at 85% I would say and there will be some interesting trading days abaj